Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis

Journal of Neuropathology and Experimental Neurology
Matthew D CykowskiS H Appel

Abstract

To determine the significance of TAR DNA binding protein 43 kDa (TDP-43) pathology in amyotrophic lateral sclerosis (ALS), we examined the whole brains and spinal cords of 57 patients (35 men; 22 women; mean age 63.3 years; 15 patients with c9orf72-associated ALS [c9ALS]). TDP-43 pathologic burden was determined relative to symptom onset site, disease duration, progression rate, cognitive status, and c9ALS status. There was a trend for greater TDP-43 pathologic burden in cognitively impaired patients (p = 0.07), though no association with disease duration or progression rate was seen. Shorter disease duration (p = 0.0016), more severe striatal pathology (p = 0.0029), and a trend toward greater whole brain TDP-43 pathology (p = 0.059) were found in c9ALS. Cluster analysis identified "TDP43-limited," "TDP43-moderate," and "TDP43-severe" subgroups. The TDP43-limited group contained more cognitively intact (p = 0.005) and lower extremity onset site (p = 0.019) patients, while other subgroups contained more cognitively impaired patients. We conclude that TDP-43 pathologic burden in ALS is associated with cognitive impairment and c9ALS, but not duration of disease or rate of progression. Further, we demonstrate a subgroup of patients...Continue Reading

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoI Nakano
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Jul 1, 1994·Muscle & Nerve·J M KillianD Boland
Jan 5, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·M J Strong
Aug 24, 2005·Neurology·G M RingholzP E Schulz
Sep 13, 2005·Current Opinion in Neurology·Rositsa BaltadzhievaAmos D Korczyn
Jun 15, 2007·Acta Neuropathologica·Dennis W DicksonCatalina Amador-Ortiz
Oct 3, 2007·Neurology·M W WheatonP E Schulz
Sep 20, 2008·PLoS Genetics·Nicola J RutherfordRosa Rademakers
Jan 14, 2009·Archives of Neurology·Leo F McCluskeyJohn Q Trojanowski
Sep 1, 2009·Biochimica Et Biophysica Acta·Ping ShiHaining Zhu
Nov 20, 2009·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Adriano ChiòUNKNOWN Eurals Consortium
May 27, 2010·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Ali JawaidPaul E Schulz
Jul 30, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Rebecca M Wolf GilbertLewis P Rowland
Sep 25, 2010·Lancet Neurology·Ian Ra MackenzieManuela Neumann
Mar 1, 2012·Brain : a Journal of Neurology·Johnathan Cooper-KnockPamela J Shaw
Mar 20, 2012·Acta Neuropathologica·Johannes BrettschneiderJohn Q Trojanowski
Nov 3, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·David J IrwinMurray Grossman
Nov 13, 2012·EMBO Molecular Medicine·Jenny S HenkelStanley H Appel
May 25, 2013·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·John RavitsSteven Ringel
May 21, 2013·Annals of Neurology·Johannes BrettschneiderJohn Q Trojanowski
Nov 13, 2013·Nature Reviews. Neurology·Heiko BraakKelly Del Tredici
Nov 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Tao ZuLaura P W Ranum
Dec 21, 2013·Acta Neuropathologica·Ian R A MackenzieManuela Neumann
Mar 25, 2014·Acta Neuropathologica·Keith A JosephsDennis W Dickson
Jun 12, 2014·Acta Neuropathologica·Johannes BrettschneiderJohn Q Trojanowski
Aug 12, 2014·Experimental Neurology·John Ravits
Dec 30, 2014·Acta Neuropathologica Communications·Matthew D CykowskiSuzanne Z Powell
Jan 9, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Kristopher G HootenStanley H Appel
May 2, 2015·The Journal of Clinical Investigation·Owen M PetersRobert H Brown
Jun 2, 2015·The Journal of Clinical Investigation·Owen M PetersRobert H Brown
Jul 21, 2015·Nature Neuroscience·Mercedes PrudencioLeonard Petrucelli
Jul 29, 2015·Acta Neuropathologica Communications·Manaal FatimaJillian J Kril
Mar 14, 2016·Journal of Neuropathology and Experimental Neurology·Matthew D CykowskiPeter T Nelson
May 23, 2016·Journal of Neuropathology and Experimental Neurology·Peter T NelsonEseosa T Ighodaro
Aug 5, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Paul MehtaKevin Horton
Nov 1, 2016·Brain : a Journal of Neurology·Sarat C VatsavayaiWilliam W Seeley

❮ Previous
Next ❯

Citations

Dec 24, 2018·Neuropathology and Applied Neurobiology·B BorroniE Buratti
Nov 2, 2018·Neuroscience Bulletin·Xiaoling ZhangKeqing Zhu
Sep 14, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Jenna M GregorySharon Abrahams
Nov 2, 2019·Journal of Neuroinflammation·Javier H JaraP Hande Özdinler
Oct 1, 2020·Neuroscience Insights·Mara-Luciana Floare, Scott P Allen
Dec 24, 2017·Acta Neuropathologica·Christopher M HenstridgeTara L Spires-Jones
May 16, 2018·Frontiers in Molecular Neuroscience·Qing ZhangXiaochuan Wang
Nov 16, 2019·Molecular Neurodegeneration·Raphaella W L SoGerold Schmitt-Ulms
Apr 20, 2019·Neuropathology and Applied Neurobiology·J MollinkA M van Cappellen van Walsum
Sep 12, 2020·Neurology·Ignacio Illán-GalaRicard Rojas-García
Dec 18, 2020·Frontiers in Neurology·Michael J StrongKathryn Volkening
Apr 2, 2021·The EMBO Journal·Maria Elena CicardiDavide Trotti
Apr 8, 2021·Brain : a Journal of Neurology·Belen PascualJoseph C Masdeu
Aug 13, 2021·Journal of Neuropathology and Experimental Neurology·Sahara J CathcartMatthew D Cykowski

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.